MRVL vs UNH: Which Is the Better Buy?
Side-by-side comparison of Marvell Technology, Inc. and UnitedHealth Group Incorporated — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-09-25.
Marvell Technology, Inc. · Technology
$258.95
-11.4% upside to fair value
Med Conviction
Grade C
High Quality
VS
UnitedHealth Group Incorporated · Healthcare
$375.21
+28.2% upside to fair value
Med Conviction
Grade B
High Quality
QuantHub Verdict
UNH has more upside to fair value
(+28.2%).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
MRVL |
UNH |
| Current Price |
$258.95 |
$375.21 |
| Fair Value Estimate |
$229.46 |
$481.06 |
| Upside to Fair Value |
-11.4%
|
+28.2%
|
| Market Cap |
$226.8B |
$340.7B |
| Forward P/E |
—
|
—
|
| EV / EBITDA |
48.0x
|
15.0x
|
| Price / Sales |
24.0x
|
0.8x
|
| Price / FCF |
134.3x
|
14.4x
|
| Revenue Growth YoY |
+36.5%
|
+0.4%
|
| Gross Margin |
51.4%
|
22.5%
|
| Operating Margin |
16.7%
|
4.8%
|
| Return on Equity |
16.2%
|
14.6%
|
| Dividend Yield |
0.09% |
2.41% |
| FCF Yield |
0.74%
|
6.95%
|
| Analyst Consensus |
Strong Buy
|
Strong Buy
|
Investment Thesis
Marvell Technology is a data infrastructure semiconductor specialist that designs custom AI accelerators, electro-optics DSPs, ethernet switching, storage controllers and interconnect silicon for hyperscale data centers, communications and carrier markets, employing roughly 7,480 people under CEO Matthew J. Murphy. Business quality is genuinely high on the demand side: revenue grew 36.5% year ove…
UnitedHealth Group is the largest diversified healthcare enterprise in the United States, operating UnitedHealthcare insurance plans alongside Optum Health, Optum Insight, and Optum Rx, with 390,000 employees and a market capitalization of $340.74 billion. The business quality is high: a 14.6% return on equity, $26.07 in free cash flow per share, and a P/FCF of 14.39 demonstrate strong cash gener…
Accumulation Zones
| Metric |
MRVL |
UNH |
| Zone Low |
$172.09 |
$360.80 |
| Zone High |
$195.04 |
$408.90 |
| In Buy Zone? |
No
|
Yes
|